The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Assessment of pathologic response to neoadjuvant chemotherapy in locally advanced non-small cell lung cancer using FDG-PET/CT: SUVmax versus metabolic tumor volume.
M. Soussan
No relevant relationships to disclose
K. Chouahnia
No relevant relationships to disclose
M. Kambouchner
No relevant relationships to disclose
A. Khafagy
No relevant relationships to disclose
G. Des Guetz
No relevant relationships to disclose
L. H. Zelek
No relevant relationships to disclose
E. Martinod
No relevant relationships to disclose
J. F. Morere
No relevant relationships to disclose